Abstract: For efficiently generating training data, a main device includes a processor. The processor performs: a wear determination process of determining, in view of an output signal from a sub-sensor provided close to an odor sensor associated with a service user, whether the odor sensor is worn by the service user; a first acquisition process of acquiring an output signal from the odor sensor; a second acquisition process of acquiring type information indicative of a type of excretion of the service user, which has been determined by a service provider; and a training data generation process of generating h includes sensor information indicative of the output signal having been acquired in the first acquisition process from the odor sensor that has been, in the wear determination process, determined to be worn by the service user and which includes the type information having been acquired in the second acquisition process.

Abstract: An excretion care assistance device includes a processor. The processor is configured to carry out a first specification process of specifying defecation times of care-receivers on the basis of sensor terminals and a second specification process of specifying a time at which group excretion care is to be started for at least one care-receiver group, in accordance with a frequency distribution indicative of a total number of times of defecation in each of a plurality of time periods, the frequency distribution being determined from the defecation times that have been specified in the first specification process.

Abstract: In order to provide a novel determination device capable of determining the type of excretion by a subject and a related technology thereof, a determination device includes at least one processor, and the at least one processor carries out a determination process of determining the type of excretion by a subject by referring to a first gas concentration, which is a gas concentration detected by a first gas sensor, and a second gas concentration, which is a gas concentration detected by a second gas sensor that is disposed at a position farther from the subject than a position at which the first gas sensor is disposed.

Abstract: In order to provide a novel determination device capable of determining the type of excretion by a subject and a related technology thereof, a determination device includes at least one processor, and the at least one processor carries out a determination process of determining the type of excretion by a subject by referring to a first gas concentration detected by a first gas sensor and a second gas concentration detected by a second gas sensor which differs from the first gas sensor in gas species to be mainly detected.

Abstract: In order to achieve a management device capable of managing the history of the location of a care-receiver, the management device includes a processor. The processor carries out a communication process of performing communication, via any of a plurality of relay terminals, with a sensor terminal which is worn by a care-receiver and which includes an excretion sensor and a determination process of determining a location of the care-receiver, based on a relay terminal which mediated the communication with the sensor terminal in the communication process.

Abstract: Provided is a sensor device capable of detecting leakage from a pouch with a higher accuracy. An odor sensor (41) detects odor leaking from a pouch (3) attached to a stoma (21) of a user (2). A radio communication interface (42) notifies, via a notification device (5), the user (2) that odor is detected.

Abstract: An industrial machine startup control system for controlling startup of an industrial machine, the industrial machine startup control system including: a vital data measurement device that measures vital data of a worker; a health state analysis device that acquires the vital data of the worker measured by the vital data measurement device, and that determines a health state of the worker based on the acquired vital data; and a startup control device that controls whether or not to allow startup of the industrial machine based on the determination result from the health state analysis device.

Abstract: An industrial machine startup control system for controlling startup of an industrial machine, the industrial machine startup control system including: a vital data measurement device that measures vital data of a worker; a health state analysis device that acquires the vital data of the worker measured by the vital data measurement device, and that determines a health state of the worker based on the acquired vital data; and a startup control device that controls whether or not to allow startup of the industrial machine based on the determination result from the health state analysis device.

Abstract: It is an object of the present invention to provide a method of evaluating whether or not a subject has a predisposition to obesity or an obesity-related condition or disease, a kit for conducting the method, an anti-obesity drug having an effect of preventing or treating obesity or an obesity-related condition or disease, a method of screening the anti-obesity drug, a non-human animal having a deficiency in the gene associated with obesity, and an adipose tissue or adipocyte of the animal. The method of evaluating a predisposition to obesity of the present invention is a method of evaluating whether or not a subject has a predisposition to obesity or an obesity-related condition or disease. The method includes the step of detecting a copy number variation (CNV) in intron 1 of SLC25A24 gene or a gene polymorphism having a linkage disequilibrium relationship with the CNV in a sample containing a human gene of the subject.

Abstract: It is an object of the present invention to provide a method of evaluating whether or not a subject has a predisposition to obesity or an obesity-related condition or disease, a kit for conducting the method, an anti-obesity drug having an effect of preventing or treating obesity or an obesity-related condition or disease, a method of screening the anti-obesity drug, a non-human animal having a deficiency in the gene associated with obesity, and an adipose tissue or adipocyte of the animal. The method of evaluating a predisposition to obesity of the present invention is a method of evaluating whether or not a subject has a predisposition to obesity or an obesity-related condition or disease. The method includes the step of detecting a copy number variation (CNV) in intron 1 of SLC25A24 gene or a gene polymorphism having a linkage disequilibrium relationship with the CNV in a sample containing a human gene of the subject.

Abstract: A method and system is provided to determine or estimate components that may have to be maintained before a molding system that has those components is caused to be stopped by problems with those components. Cycle times that each correspond to the time of the cycle of each operation of the molding system and operation times of the steps performed by the components, which operation times affect the cycle times, are measured and stored. Based on the sum of the operation times that exceed a predetermined time or the sum of the number of operation times that exceed the predetermined time, any step that may cause a problem among the steps of the components, which affect the cycle time, is determined.

Abstract: A method for anticipating sensitivity to a medicine for osteoporosis is provided which is characterized by analyzing respective genetic polymorphisms of a vitamin D receptor gene, an estrogen receptor gene, and an apolipoprotein E gene from a genome DNA contained in a sample obtained from a human, and anticipating, based on the analyzed combination of the genetic polymorphisms, that the sample is derived from an individual who shows a specific priority to sensitivities to a plurality of remedies for osteoporosis. A reagent for simultaneously detecting genetic polymorphisms is also provided which contains amplification primers and/or detection probes specific to respective genes of the vitamin D receptor gene, apolipoprotein E gene, and estrogen receptor gene. Further, a method for simultaneously detecting these genes, and a method for selecting remedies for bone disease based on the genetic polymorphisms are provided.

Abstract: A method for estimation of change in bone mineral density or a method for diagnosis of osteoporosis, comprising the step of measuring change in a concentration of soluble interleukin-6 receptor in a blood sample, by for example, sandwich assay or competition assay; and a kit for carrying out the methods, comprising: (1) an anti-sIL-6R antibody immobilized to a solid carrier, and (2) an anti-sIL-6R antibody bound to a detectable marker or capable of binding to a detectable marker.

Abstract: A method for estimation of change in bone mineral density or a method for diagnosis of osteoporosis, comprising the step of measuring change in a concentration of soluble interleukin-6 receptor in a blood sample, by for example, sandwich assay or competition assay; and a kit for carrying out said methods, comprising:(1) an anti-sIL-6R antibody immobilized to a solid carrier, and(2) an anti-sIL-6R antibody is bound to a detectable marker or capable of binding to a detectable marker.